{
  "extraction_metadata": {
    "company": "Visterra Inc",
    "website": "https://visterrainc.com",
    "extraction_timestamp": "2025-05-25T19:59:02.968219",
    "duration_seconds": 69.04011487960815,
    "pages_processed": 5
  },
  "raw_extractions": {
    "general": [
      {
        "page_url": "https://visterrainc.com",
        "page_path": "",
        "page_type": "general",
        "content_length": 6033,
        "extraction_timestamp": "2025-05-25T19:58:06.341151",
        "intelligence": {
          "company_profile": {
            "company_name": "Visterra, Inc.",
            "industry": "Biologics Research and Development",
            "business_model": "B2B",
            "company_description": "Visterra is a biologics research and early-stage clinical development company developing therapies for patients with immune-mediated and other hard-to-treat diseases.",
            "value_proposition": "We Bring Better Biologics to Life",
            "target_market": "Healthcare providers, pharmaceutical companies, patients with immune-mediated diseases",
            "company_stage": "Growth"
          },
          "business_metrics": {
            "employee_count": "unknown",
            "revenue_indicators": "unknown",
            "funding_status": "unknown",
            "growth_signals": [
              "Recent hiring",
              "New products"
            ],
            "market_position": "unknown",
            "geographic_presence": "unknown"
          },
          "sales_intelligence": {
            "key_decision_makers": [
              "unknown"
            ],
            "organizational_structure": "unknown",
            "technology_stack": [
              "AI",
              "Computational research methods",
              "Experimental research methods"
            ],
            "integration_partners": [
              "unknown"
            ],
            "competitive_advantages": [
              "Innovative technologies",
              "Agile preclinical development",
              "Creative trial designs"
            ],
            "recent_news": [
              "Sibeprenlimab (VIS649) is being evaluated for IgA nephropathy"
            ]
          },
          "sales_triggers": {
            "expansion_signals": [
              "unknown"
            ],
            "technology_adoption": [
              "Innovative technologies",
              "AI implementations"
            ],
            "leadership_changes": [
              "unknown"
            ],
            "financial_events": [
              "unknown"
            ],
            "product_launches": [
              "Sibeprenlimab (VIS649)"
            ]
          },
          "contact_intelligence": {
            "headquarters": "unknown",
            "contact_methods": {
              "website": "https://visterrainc.com/",
              "email": "unknown",
              "phone": "unknown",
              "social_media": [
                "LinkedIn",
                "Instagram"
              ]
            },
            "office_locations": [
              "unknown"
            ]
          },
          "competitive_landscape": {
            "competitors_mentioned": [
              "unknown"
            ],
            "market_positioning": "unknown",
            "unique_differentiators": [
              "Novel therapies engineered to augment and surpass standard of care"
            ],
            "target_customer_pain_points": [
              "Immune-mediated diseases",
              "Hard-to-treat diseases"
            ]
          },
          "_extraction_metadata": {
            "page_type": "general",
            "url": "https://visterrainc.com",
            "extraction_timestamp": 1748224686.3410912
          }
        }
      },
      {
        "page_url": "https://visterrainc.com/about-us",
        "page_path": "/about-us",
        "page_type": "general",
        "content_length": 3252,
        "extraction_timestamp": "2025-05-25T19:58:17.970826",
        "intelligence": {
          "company_profile": {
            "company_name": "Visterra, Inc.",
            "industry": "Biotechnology",
            "business_model": "B2B",
            "company_description": "Visterra is focused on bringing better biologics to life through innovative research and development.",
            "value_proposition": "We Bring Better Biologics to Life",
            "target_market": "Pharmaceutical companies, healthcare providers",
            "company_stage": "Growth"
          },
          "business_metrics": {
            "employee_count": "unknown",
            "revenue_indicators": "unknown",
            "funding_status": "unknown",
            "growth_signals": [
              "Recent hiring",
              "New products"
            ],
            "market_position": "unknown",
            "geographic_presence": "unknown"
          },
          "sales_intelligence": {
            "key_decision_makers": [
              "unknown"
            ],
            "organizational_structure": "unknown",
            "technology_stack": [
              "unknown"
            ],
            "integration_partners": [
              "unknown"
            ],
            "competitive_advantages": [
              "Innovative biologics development"
            ],
            "recent_news": [
              "New programs launched"
            ]
          },
          "sales_triggers": {
            "expansion_signals": [
              "unknown"
            ],
            "technology_adoption": [
              "unknown"
            ],
            "leadership_changes": [
              "unknown"
            ],
            "financial_events": [
              "unknown"
            ],
            "product_launches": [
              "VIS171",
              "VIS513"
            ]
          },
          "contact_intelligence": {
            "headquarters": "unknown",
            "contact_methods": {
              "website": "https://visterrainc.com/",
              "email": "unknown",
              "phone": "unknown",
              "social_media": [
                "https://www.linkedin.com/company/visterra-inc-/posts/?feedView=all",
                "https://www.instagram.com/visterrainc/?hl=en"
              ]
            },
            "office_locations": [
              "unknown"
            ]
          },
          "competitive_landscape": {
            "competitors_mentioned": [
              "unknown"
            ],
            "market_positioning": "unknown",
            "unique_differentiators": [
              "Focus on biologics"
            ],
            "target_customer_pain_points": [
              "Need for innovative biologics solutions"
            ]
          },
          "_extraction_metadata": {
            "page_type": "general",
            "url": "https://visterrainc.com/about-us",
            "extraction_timestamp": 1748224697.9708002
          }
        }
      },
      {
        "page_url": "https://visterrainc.com/contact",
        "page_path": "/contact",
        "page_type": "general",
        "content_length": 3456,
        "extraction_timestamp": "2025-05-25T19:59:01.738497",
        "intelligence": {
          "company_profile": {
            "company_name": "Visterra Inc.",
            "industry": "Biotechnology",
            "business_model": "B2B",
            "company_description": "Visterra is focused on bringing better biologics to life through innovative research and development.",
            "value_proposition": "We Bring Better Biologics to Life",
            "target_market": "Pharmaceutical companies, healthcare providers, patients",
            "company_stage": "Growth"
          },
          "business_metrics": {
            "employee_count": "unknown",
            "revenue_indicators": "unknown",
            "funding_status": "unknown",
            "growth_signals": [
              "Recent hiring",
              "New products"
            ],
            "market_position": "unknown",
            "geographic_presence": "Waltham, MA"
          },
          "sales_intelligence": {
            "key_decision_makers": [
              "unknown"
            ],
            "organizational_structure": "unknown",
            "technology_stack": [
              "unknown"
            ],
            "integration_partners": [
              "unknown"
            ],
            "competitive_advantages": [
              "Focus on biologics",
              "Innovative research"
            ],
            "recent_news": [
              "New programs launched"
            ]
          },
          "sales_triggers": {
            "expansion_signals": [
              "unknown"
            ],
            "technology_adoption": [
              "unknown"
            ],
            "leadership_changes": [
              "unknown"
            ],
            "financial_events": [
              "unknown"
            ],
            "product_launches": [
              "VIS171",
              "VIS513"
            ]
          },
          "contact_intelligence": {
            "headquarters": "275 Second Ave. 4th Floor Waltham, MA 02451",
            "contact_methods": {
              "website": "https://visterrainc.com/",
              "email": "info@visterrainc.com",
              "phone": "(617) 498-1070",
              "social_media": [
                "https://www.linkedin.com/company/visterra-inc-/posts/?feedView=all",
                "https://www.instagram.com/visterrainc/?hl=en"
              ]
            },
            "office_locations": [
              "275 Second Ave. 4th Floor Waltham, MA 02451"
            ]
          },
          "competitive_landscape": {
            "competitors_mentioned": [
              "unknown"
            ],
            "market_positioning": "unknown",
            "unique_differentiators": [
              "Focus on biologics",
              "Innovative research"
            ],
            "target_customer_pain_points": [
              "Need for effective biologics",
              "Challenges in drug development"
            ]
          },
          "_extraction_metadata": {
            "page_type": "general",
            "url": "https://visterrainc.com/contact",
            "extraction_timestamp": 1748224741.738454
          }
        }
      }
    ],
    "leadership": [
      {
        "page_url": "https://visterrainc.com/leadership",
        "page_path": "/leadership",
        "page_type": "leadership",
        "content_length": 10673,
        "extraction_timestamp": "2025-05-25T19:58:38.700351",
        "intelligence": {
          "leadership_team": [
            {
              "name": "Greg Babcock, PhD",
              "title": "Senior Vice President, Research",
              "department": "Research",
              "seniority_level": "VP",
              "background": "25 years of experience researching and developing monoclonal antibodies; previously Deputy Director.",
              "tenure": "Since 2013",
              "decision_making_power": "Strategic decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Jean L. Bender",
              "title": "Vice President, Pharmaceutical Sciences and Technology",
              "department": "Pharmaceutical Sciences",
              "seniority_level": "VP",
              "background": "Led BioProcess Engineering at Medimmune LLC; responsible for process development engineering.",
              "tenure": "Not mentioned",
              "decision_making_power": "Strategic decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Todd Curtis, MBA, CPA",
              "title": "Chief Financial Officer",
              "department": "Finance",
              "seniority_level": "C-level",
              "background": "More than 15 years of finance and operations leadership experience in biotechnology and software sectors.",
              "tenure": "Since 2015",
              "decision_making_power": "Budget and financial decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Chris Kiefer, JD",
              "title": "Chief Operating Officer",
              "department": "Operations",
              "seniority_level": "C-level",
              "background": "Held senior positions at Momenta Pharmaceuticals, Ironwood Pharmaceuticals, and Genzyme Corporation; began career as a corporate attorney.",
              "tenure": "Not mentioned",
              "decision_making_power": "Strategic and operational decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Asher Schachter, MD",
              "title": "Vice President, Translational Medicine",
              "department": "Translational Medicine",
              "seniority_level": "VP",
              "background": "Practiced clinical pediatric nephrology at Boston Children’s Hospital; conducted translational research.",
              "tenure": "Since 2020",
              "decision_making_power": "Strategic decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Zachary Shriver, PhD",
              "title": "President and Chief Executive Officer",
              "department": "Executive",
              "seniority_level": "C-level",
              "background": "25 years of experience in the biotechnology industry; joined Visterra in 2009 as VP of Research.",
              "tenure": "Since 2009",
              "decision_making_power": "Strategic decisions",
              "contact_hints": "LinkedIn profile available"
            },
            {
              "name": "Susan Sloan, PhD",
              "title": "Vice President, Nonclinical Development",
              "department": "Nonclinical Development",
              "seniority_level": "VP",
              "background": "Responsible for IND-enabling and early-phase development activities; oversees Quality function.",
              "tenure": "Since 2013",
              "decision_making_power": "Strategic decisions",
              "contact_hints": "LinkedIn profile available"
            }
          ],
          "organizational_insights": {
            "company_size_indicators": "7 key leaders mentioned, indicating a mid-sized organization.",
            "department_structure": [
              "Research",
              "Pharmaceutical Sciences",
              "Finance",
              "Operations",
              "Translational Medicine",
              "Nonclinical Development"
            ],
            "growth_indicators": [
              "Recent hires include Asher Schachter in 2020",
              "Zachary Shriver has been with the company since 2009, indicating stability and potential growth"
            ],
            "company_culture": "Emphasis on research and development, collaboration, and strategic decision-making.",
            "hiring_signals": []
          },
          "sales_targeting": {
            "key_buyers": [
              "Todd Curtis, CFO",
              "Zachary Shriver, CEO"
            ],
            "technical_influencers": [
              "Greg Babcock, SVP Research",
              "Jean L. Bender, VP Pharmaceutical Sciences and Technology"
            ],
            "business_stakeholders": [
              "Chris Kiefer, COO",
              "Asher Schachter, VP Translational Medicine"
            ],
            "entry_points": [
              "Greg Babcock, SVP Research",
              "Jean L. Bender, VP Pharmaceutical Sciences and Technology"
            ]
          },
          "_extraction_metadata": {
            "page_type": "leadership",
            "url": "https://visterrainc.com/leadership",
            "extraction_timestamp": 1748224718.700222
          }
        }
      }
    ],
    "product": [
      {
        "page_url": "https://visterrainc.com/services",
        "page_path": "/services",
        "page_type": "product",
        "content_length": 3481,
        "extraction_timestamp": "2025-05-25T19:58:48.795797",
        "intelligence": {
          "product_portfolio": {
            "primary_offerings": [
              "Biologics development",
              "Pipeline programs",
              "Clinical trials"
            ],
            "service_categories": [
              "Research services",
              "Clinical trial management",
              "Biologics manufacturing"
            ],
            "target_use_cases": [
              "Improving biologics efficacy",
              "Streamlining clinical trials",
              "Enhancing drug development processes"
            ],
            "pricing_models": "Not explicitly mentioned",
            "product_maturity": "Established products"
          },
          "market_intelligence": {
            "target_industries": [
              "Biotechnology",
              "Pharmaceuticals",
              "Healthcare"
            ],
            "customer_segments": [
              "Enterprise",
              "Mid-market"
            ],
            "geographic_markets": [
              "North America",
              "Europe"
            ],
            "vertical_specialization": [
              "Biologics",
              "Clinical research"
            ],
            "customer_examples": [
              "Not specified"
            ]
          },
          "competitive_positioning": {
            "value_propositions": [
              "Innovative biologics solutions",
              "Expertise in clinical trial management",
              "Focus on patient outcomes"
            ],
            "differentiators": [
              "Strong research foundation",
              "Tailored pipeline programs",
              "Commitment to improving biologics"
            ],
            "technology_advantages": [
              "Advanced research methodologies",
              "Proprietary development processes"
            ],
            "market_approach": "Direct engagement with biotech and pharmaceutical companies",
            "partnership_strategy": [
              "Collaborations with research institutions",
              "Alliances with healthcare providers"
            ]
          },
          "sales_opportunities": {
            "solution_gaps": [
              "Need for enhanced clinical trial efficiency",
              "Demand for innovative biologics"
            ],
            "technology_needs": [
              "Integration with clinical data management systems",
              "Advanced analytics tools"
            ],
            "scaling_challenges": [
              "Expanding into new geographic markets",
              "Increasing production capacity"
            ],
            "integration_opportunities": [
              "Clinical trial management systems",
              "Biologics manufacturing platforms"
            ],
            "expansion_signals": [
              "Growing interest in biologics",
              "Increased funding for biotech innovations"
            ]
          },
          "_extraction_metadata": {
            "page_type": "product",
            "url": "https://visterrainc.com/services",
            "extraction_timestamp": 1748224728.795779
          }
        }
      }
    ],
    "news": []
  }
}